SynAct Pharma AB · OMXSTO:SYNACT

Quantass ApS sold 150,000 SynAct Pharma AB shares (MAR article 19 notification)

Traded Sep 2, 2026 · Filed Sep 7, 2026 · Read by 6ix Oct 14, 2026

On Sep 2, 2026, Quantass ApS (Closely associated with Jeppe Øvlesen (Chief Executive Officer (CEO)/Managing Directory)) sold 150,000 SynAct Pharma AB shares at SEK 17.80 for SEK 2.67M. Filed Sep 7, 2026 (MAR article 19 notification).

Sold
150,000 shares
Price
SEK 17.80
Value
SEK 2.67M
Role
Closely associated with Jeppe Øvlesen (Chief Executive Officer (CEO)/Managing Directory)

The register entry

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 2, 2026SynAct Pharma ABSale150,000SEK 17.80Indirect

Source

View original at Finansinspektionen

Related